Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.

PloS one - 1 Jan 2017

Kim Hyungjin, Park Chang Min, Keam Bhumsuk, Park Sang Joon, Kim Miso, Kim Tae Min, Kim Dong-Wan, Heo Dae Seog, Goo Jin Mo

Abstract excerpt

PURPOSE: To determine if the radiomic features on CT can predict progression-free survival (PFS) in epidermal growth factor receptor (EGFR) mutant adenocarcinoma patients treated with first-line EGFR tyrosine kinase inhibitors (TKIs) and to identify the incremental value of radiomic features over conventional clinical factors in PFS prediction. METHODS: In this institutional review board-approved retrospective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Prognosis

Share to Proportional Hazards Models

Share to Regression Analysis

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 29099855
DOI: 10.1371/journal.pone.0187500
PMCID: PMC5669442

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.PMID 29099855Read ↗

Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.Semantic proximity Read ↗

Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.Semantic proximity Read ↗

Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation.Semantic proximity Read ↗

Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutationSemantic proximity Read ↗

Using Multi-phase CT Radiomics Features to Predict EGFR Mutation Status in Lung Adenocarcinoma Patients.Semantic proximity Read ↗

Using CT image-based radiomics to predict EGFR mutations in lung adenocarcinomaSemantic proximity Read ↗

CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statusesSemantic proximity Read ↗

Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after ChemoradiationSemantic proximity Read ↗

IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.Semantic proximity Read ↗

Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphologySemantic proximity Read ↗

PET/CT radiomics and machine learning enable non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinomaSemantic proximity Read ↗

A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.